Literature DB >> 2818650

[Synthesis and immunochemical properties of peptides corresponding to sequences 59-72 and 25-36 of human interleukin-2].

L V Onoprienko, I I Mikhaleva, V E Lunev, V A Nesmeianov, V T Ivanov.   

Abstract

Synthesis of peptides corresponding to the 59-72 and 25-36 sequences of human IL-2 is reported. The former peptide, which had been shown to be immunogenic in the protein molecule, was prepared to obtain antipeptide antibodies for isolation and purification of the recombinant IL-2. We located the epitope at the C-terminus of this peptide. In accordance with the IL-2 secondary structure and hydrophilicity profile analysis, the 25-36 fragment was chosen as the potential epitope. The peptides were synthesized by conventional methods in solution, conjugated with a protein carrier, and polyclonal rabbit antisera were obtained. Antibodies against both peptides were shown to be specific to human IL-2 in ELISA. Besides, monoclonal antibodies to IL-2 recognized in ELISA the 59-72 peptide, suggesting the epitope located in this region to be main one in the protein molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818650

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  2 in total

1.  Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.

Authors:  P V Afonin; A V Fokin; I N Tsygannik; I Y Mikhailova; L V Onoprienko; I I Mikhaleva; V T Ivanov; T Y Mareeva; V A Nesmeyanov; N Li; W A Pangborn; W L Duax; V Z Pletnev
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

2.  Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides.

Authors:  Tammy Price-Troska; Zhi-Zhang Yang; David Diller; Alexander Bayden; Mark Jarosinski; Joseph Audie; Stephen M Ansell
Journal:  Invest New Drugs       Date:  2018-04-26       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.